Related Experiment Video
Updated: May 21, 2026

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
Medication error: Subarachnoid injection of tranexamic acid
Bina P Butala1, Veena R Shah, Guruprasad P Bhosale
1Department of Anaesthesia and Critical Care, Smt. K. M. Mehta and Smt. G. R. Doshi Institute of Kidney Diseases and Research Center, Dr. H. L. Trivedi Institute of Transplantation Sciences, Civil Hospital Campus, Asarwa, Ahmedabad, Gujarat, India.
Accidental intrathecal injection of tranexamic acid instead of Bupivacaine during spinal anesthesia caused patient myoclonus. Prompt treatment with anticonvulsants and supportive care led to full recovery, highlighting medication safety risks.
Area of Science:
- Anesthesiology
- Pharmacology
- Patient Safety
Background:
- Medical errors can stem from factors like ampoule labeling, appearance, and storage.
- Drug mix-ups during anesthesia pose significant patient risks.
Purpose of the Study:
- To report a case of accidental intrathecal injection of tranexamic acid instead of Bupivacaine.
- To discuss the management and outcomes of this medication error.
Main Methods:
- A case report detailing an accidental drug substitution during spinal anesthesia.
- Clinical observation of patient's symptoms, including myoclonus.
- Review of ampoule appearance and identification of the incorrect drug.
- Description of pharmacological and supportive treatments administered.
Main Results:
- Accidental intrathecal injection of tranexamic acid occurred due to similar ampoule appearance.
- Patient developed lower extremity myoclonus post-injection.
- Myoclonus was successfully managed with phenytoin, sodium valproate, and infusions.
- Patient experienced a full recovery with no long-term sequelae.
Conclusions:
- Similarities in drug packaging can lead to critical medication errors in anesthesia.
- Vigilance in drug identification and administration is crucial for patient safety.
- Prompt and appropriate medical intervention can effectively manage adverse drug events.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Venous Thrombosis III: Interprofessional Care
Prevention of Further Absorption of Poison
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Anticoagulant Drugs: Low-Molecular-Weight Heparins

